Sbd
P123 - Segurança CV da Dulaglutida - estudo REWIND - Roberto Betti
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:03:33
- More information
Informações:
Synopsis
Ref: Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019 Jul 13;394(10193):121-130.
